Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Preparing for next pandemic, Korea's SK pumps $261M into vaccine R&D site
Fierce Biotech
Wed, 02/8/23 - 10:32 am
SK Bioscience
COVID-19
vaccines
R&D
New York City invests $20M into biotech 'innovation space' at the Brooklyn Navy Yard
Endpoints
Tue, 01/31/23 - 11:28 pm
NYC
innovation
R&D
biotech
Biotech CFOs eye research cuts, partnerships amid sector retrenchment: report
BioPharma Dive
Mon, 01/30/23 - 10:52 am
biotech
CFOs
R&D
funding
IPOs
Federal panel approves plans to safeguard lab-made virus research
Stat
Sun, 01/29/23 - 01:27 pm
viruses
R&D
gain of function
drug development
Construction on Merck's London research hub set to begin in April 2023
Endpoints
Wed, 01/25/23 - 10:40 pm
Merck
London
R&D
UK
Georgia Tech spinout bags cash for nucleic acid delivery R&D
Fierce Pharma
Tue, 01/24/23 - 06:13 pm
Piezo Therapeutics
drug delivery
nucleic acid delivery
Georgia Tech
R&D
Califf: Current evidence generation system in clinical research needs an overhaul
RAPS.org
Tue, 01/24/23 - 10:22 am
FDA
Robert Califf
R&D
clinical trials
Morphic Loses Another Big Pharma as J&J Bails on Research Deal
BioSpace
Mon, 01/23/23 - 11:13 am
JNJ
Janssen
Morphic Therapeutic
R&D
Sanofi and CytoReason target IBD in expanded collaboration
Pharma Live
Mon, 01/23/23 - 11:03 am
Sanofi
CytoReason
IBD
R&D
Merck KGaA shrinks U.S. research team as layoffs continue to batter industry
Fierce Biotech
Mon, 01/23/23 - 10:48 am
Merck KGaA
layoffs
R&D
Gilead fosters growth with plans for new research center in California hometown
Fierce Biotech
Wed, 01/18/23 - 11:04 pm
Gilead Sciences
R&D
California
Qiagen picks up DNA forensics company for $150M
Endpoints
Mon, 01/9/23 - 10:23 am
R&D
forensic genetics
Qiagen
M&A
Verogen
Pfizer pivots from early-stage rare disease R&D, shifting to external innovation and putting assets up for sale
Fierce Biotech
Fri, 01/6/23 - 10:09 am
Pfizer
R&D
externalization
gene therapy
Rare Diseases
Biogen splits R&D executive role, promoting interim head Singhal
BioPharma Dive
Thu, 01/5/23 - 04:47 pm
Biogen
R&D
Merck KGaA hands over IL-12-targeting cancer med to PDS Biotech in $121M deal
Fierce Biotech
Tue, 01/3/23 - 10:26 pm
Merck KGaA
R&D
PDS Biotechnology
How a US Recession Could Affect Biopharma
BioSpace
Thu, 12/22/22 - 10:54 am
economy
biotech
recession
clinical trials
R&D
pandemic
Catalent to build a new $40M analytical services facility in North Carolina's Research Triangle
Endpoints
Wed, 12/14/22 - 07:25 pm
Catalent
North Carolina
RTP
analytical services
R&D
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
Fierce Biotech
Wed, 12/14/22 - 10:44 am
Exicure
AbbVie
Ipsen
R&D
Teva-partnered MedinCell bags $42M loan for long-acting injectable R&D
Fierce Pharma
Wed, 11/30/22 - 10:35 am
MedinCell
Teva Pharmaceutical
injectables
R&D
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs
BioSpace
Tue, 11/29/22 - 08:25 pm
Merck
BigHat Biosciences
R&D
artificial intelligence
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »